高级检索
当前位置: 首页 > 详情页

REGN2810联合双药化疗治疗晚期或转移性非小细胞肺癌

文献详情

编号/登记号:
注册时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究设计:
研究类型:
药物名称:
药物类型:
伦理委员会审批: 批准本研究的伦理委员会名称: 伦理委员会审批时间:
伦理委员会审批: 批准本研究的伦理委员会名称: 伦理委员会审批时间:
研究负责人:
研究参与人:
研究单位: [1]上海市肺科医院 [2]53]Penang Adventist Hospital [3]首都医科大学附属北京友谊医院 [4]山东大学附属济南市中心医院 [5]河北大学附属医院 [6]新疆医科大学附属肿瘤医院 [7]浙江大学医学院第一附属医院 [8]浙江大学医学院第二附属医院 [9]复旦大学附属华东医院 [10]河南省人民医院 [11]南京医科大学第二附属医院 [12]广州医科大学附属第一医院 [13]襄阳中心医院 [14]广东药科大学附属第一医院 [15]河南省肿瘤医院 [16]杭州市第一人民医院 [17]安徽省肿瘤医院 [18]福州肺科医院 [19]辽宁省肿瘤医院 [20]湖南省肿瘤医院 [21]临沂市肿瘤医院 [22]RCCA MD,LLC [23]Innovative Clinical Research Institute (ICRI) [24]Baptist Health Cancer Center [25]Cancer Center of Kansas [26]Pinellas Hematology and Oncology [27]Desert Hematology Oncology Medical Group, Inc [28]Quincy Physicians & Surgeons Clinic, S.C. [29]Northwestern Medicine Cancer Center Warrenville [30]The Oncology Institute of Hope & Innovation [31]San Juan Oncology Associates [32]Comprehensive Cancer Centers Of Nevada [33]MultiCare Institute for Research and Innovation [34]ACRC/ Arizona Clinical Research Center, Inc. [35]Mid-Florida Hematology & Oncology Centers, PA [36]Forsyth Memorial Hospital dba Novant Health Oncology Specialists [37]Gettysburg Cancer Center [38]Genesis Cancer Center [39]Samsung Medical Center [40]Severance Hospital, Yonsei University Health System [41]Gachon University Gil Medical Center [42]Korea University Anam Hospital [43]The Catholic University of Korea, Seoul St. Mary's Hospital [44]CHA Bundang Medical Center-CHA University [45]Asan Medical Center [46]Ajou University Hospital [47]Seoul National University Bundang Hospital [48]Chungbuk National University Hospital (CBNUH) [49]VHS Medical Center [50]Kyung Hee University Hospital [51]Chonbuk National University Hospital [52]Chungnam National University Hospital (CNUH) [53]Hospital Pulau Pinang [54]University Malaya Medical Centre [55]Universiti Kebangsaan Malaysia Medical Centre (UKMMC) [56]Hospital Sultan Ismail [57]Mount Miriam Cancer Hospital [58]Hospital Tengku Ampuan Afzan (HTAA) - International Islamic University Malaysia (IIUM) [59]Sabah Women and Children Hospital [60]Pantai Hospital Kuala Lumpur [61]Udonthani Cancer Center [62]Faculty of Medicine-Naresuan University [63]Lopburi Cancer Hospital [64]Phramongkutklao College of Medicine [65]Lampang Cancer Hospital [66]Prince Of Songkla Hospital, Prince Of Songkhla University [67]Chiangrai Prachanukroh Hospital [68]Khon Kaen Hospital [69]Rajavithi Hospital [70]Wiener Krankenanstaltenverbund, Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhugel [71]Nemocnice Novy Jicin a.s. [72]NH Hospital [73]Fakultni nemocnice Ostrava [74]Centre Hospitalier Intercommunal de Creteil (CHIC) - Centre de ressources et de competences pour la mucoviscidose (C.R.C.M.) [75]Centre Hospitalier General De Mont De Marsan [76]Clinique Victor Hugo [77]Hopital Instruction des armees - Begin [78]Institut de Cancerologie de l'Ouest (ICO)- CRLCC Rene Gauducheau [79]Chu Poitiers-Pole Regional De Cancerologie [80]Chu Pontchaillou [81]Hopitaux Universitaires de Strasbourg - Hopital Civil (NHC) [82]Centre Hospitalier Regional Universitaire (CHRU) Montpellier - Hopital Lapeyronie [83]Clinique Capio de Bayonne [84]Hopital Albert Calmette [85]Centre Hospitalier Lyon Sud [86]Multiprofile Clinic Consilium Medulla [87]High Technology Medical Center, University Clinic Tbilisi [88]LTD High Technology Hospital Medcenter [89]LTD Acad. F.Todua Medical Center-LTD Research Institute of Clinical Medicine [90]LTD Institute of Clinical Oncology [91]JSC Neo Medi [92]Cancer Hospital of Kifisia Oi Agioi Anargiroi [93]Interbalkan Medical Center [94]BioClinic Thessaloniki [95]Euromedica General Clinic [96]Metropolitan General Hospital [97]University General Hospital Of Larissa [98]General Hospital of Kifissia Agioi Anargiroi [99]Sotiria General Hospital of Athens [100]Ongology Theageneio Thessaloniki [101]Henry Dunant Hospital Center [102]Beaumont Hospital-Cancer Clinical Trials [103]University Hospital Limerick

研究目的:
主要目的:第1部分研究:比较cemiplimab 合并4 个疗程以铂为基础的双药化疗(cemiplimab/chemo-f) 和. cemiplimab 合并 2 个疗程以铂为基础的双药化疗(chemo-l)以及伊匹木单抗(cemiplimab/chemo-l/ipi) vs. 以铂为基础的双药化疗在晚期鳞状或非鳞状肿瘤细胞表达PD-L1 <50%的NSCLC 患者一线治疗时的总生存期(OS)。第2 部分研究:比较 cemiplimab/chemo-f 与安慰剂/chemo-f 在作为晚期鳞状或非鳞状NS

资源点击量:15101 今日访问量:4 总访问量:964 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号